(Q79219448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Ventricular remodeling in heart failure: a credible surrogate endpoint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

20 December 2019

main subject

ventricular remodeling

1 reference

based on heuristic

inferred from title

1 reference

Crossref

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

26 March 2024

James E Udelson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jay N Cohn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marvin A. Konstam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583894

26 March 2024

Inder S. Anand

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583894

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583894

26 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S1071916403006481?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

https://api.elsevier.com/content/article/PII:S1071916403006481?httpAccept=text/plain

26 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Journal of Cardiac Failure

26 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

350-353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

Surrogate end points in heart failure

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Ventricular enlargement and reduced survival after myocardial infarction

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angi

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

26 March 2024

1 reference

https://api.crossref.org/works/10.1054/J.CARDFAIL.2003.09.001

26 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583894%20AND%20SRC:MED&resulttype=core&format=json